Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMN AMN Healthcare Services	$22.00 +6.4%	$21.11	$17.45 ▼ $70.07	$791.34M	0.18	894,007 shs	833,590 shs
BRBR BellRing Brands	$58.74 +1.4%	$64.20	$48.06 ▼ $80.67	$7.36B	0.71	1.38 million shs	2.10 million shs
HAE Haemonetics	$76.39 +2.4%	$68.51	$55.30 ▼ $94.99	$3.58B	0.39	668,017 shs	724,389 shs
LNTH Lantheus	$79.42 -3.0%	$83.94	$73.11 ▼ $126.89	$5.66B	0.12	1.01 million shs	931,757 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMN AMN Healthcare Services	+6.13%	+1.57%	+4.31%	-5.66%	-55.39%
BRBR BellRing Brands	+1.45%	-1.82%	-6.78%	-23.65%	+1.35%
HAE Haemonetics	+2.16%	+4.28%	+12.87%	+19.19%	-7.72%
LNTH Lantheus	-2.98%	-1.89%	+5.18%	-18.48%	-0.72%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMN AMN Healthcare Services	4.2042 of 5 stars	3.1	1.0	4.3	2.5	1.7	1.9
BRBR BellRing Brands	3.9869 of 5 stars	4.4	3.0	0.0	2.7	2.5	1.3
HAE Haemonetics	4.8519 of 5 stars	4.5	2.0	4.3	2.1	1.7	2.5
LNTH Lantheus	4.3361 of 5 stars	3.5	1.0	4.2	1.6	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMN AMN Healthcare Services	2.25	Hold	$32.08	45.83% Upside
BRBR BellRing Brands	2.81	Moderate Buy	$77.00	31.09% Upside
HAE Haemonetics	2.91	Moderate Buy	$96.80	26.72% Upside
LNTH Lantheus	3.00	Buy	$130.50	64.32% Upside

Current Analyst Ratings Breakdown

Latest AMN, HAE, BRBR, and LNTH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/26/2025	HAE Haemonetics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$87.00
6/25/2025	HAE Haemonetics	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/23/2025	LNTH Lantheus	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$122.00 ➝ $109.00
5/28/2025	BRBR BellRing Brands	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$85.00 ➝ $75.00
5/27/2025	BRBR BellRing Brands	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$85.00
5/20/2025	HAE Haemonetics	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$100.00 ➝ $100.00
5/15/2025	BRBR BellRing Brands	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$85.00
5/13/2025	AMN AMN Healthcare Services	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$30.00 ➝ $25.50
5/9/2025	HAE Haemonetics	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Strong-Buy ➝ Strong-Buy	$115.00 ➝ $105.00
5/8/2025	BRBR BellRing Brands	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$75.00 ➝ $65.00
5/8/2025	HAE Haemonetics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$104.00 ➝ $84.00

(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMN AMN Healthcare Services	$2.98B	0.28	$14.57 per share	1.51	$18.56 per share	1.19
BRBR BellRing Brands	$2.00B	3.74	$2.30 per share	25.55	($1.60) per share	-36.71
HAE Haemonetics	$1.36B	2.70	$7.38 per share	10.35	$16.34 per share	4.67
LNTH Lantheus	$1.53B	3.58	$6.88 per share	11.54	$15.65 per share	5.07

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMN AMN Healthcare Services	-$146.98M	-$4.33	N/A	9.09	N/A	-5.80%	13.39%	4.17%	8/6/2025 (Estimated)
BRBR BellRing Brands	$246.50M	$2.15	27.32	23.13	1.83	12.82%	-133.63%	32.69%	8/4/2025 (Estimated)
HAE Haemonetics	$167.68M	$3.31	23.08	15.16	1.21	12.32%	26.37%	9.22%	8/14/2025 (Estimated)
LNTH Lantheus	$312.44M	$3.52	22.56	12.59	N/A	16.55%	36.99%	20.55%	7/30/2025 (Estimated)

Latest AMN, HAE, BRBR, and LNTH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	LNTH Lantheus	$1.65	N/A	N/A	N/A	$389.69 million	N/A
5/8/2025	Q1 2025	AMN AMN Healthcare Services	$0.19	$0.45	+$0.26	-$0.03	$670.08 million	$689.53 million
5/8/2025	Q4 2025	HAE Haemonetics	$1.22	$1.24	+$0.02	$1.17	$329.38 million	$330.60 million
5/7/2025	Q1 2025	LNTH Lantheus	$1.64	$1.53	-$0.11	$1.02	$377.37 million	$372.76 million
5/5/2025	Q2 2025	BRBR BellRing Brands	$0.53	$0.53	N/A	$0.45	$577.56 million	$588.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMN AMN Healthcare Services	N/A	N/A	N/A	N/A	N/A
BRBR BellRing Brands	N/A	N/A	N/A	N/A	N/A
HAE Haemonetics	N/A	N/A	N/A	N/A	N/A
LNTH Lantheus	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMN AMN Healthcare Services	1.39	1.08	1.08
BRBR BellRing Brands	N/A	2.92	1.34
HAE Haemonetics	1.12	1.62	0.99
LNTH Lantheus	0.49	5.74	5.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMN AMN Healthcare Services	99.23%
BRBR BellRing Brands	94.97%
HAE Haemonetics	99.67%
LNTH Lantheus	99.06%

Insider Ownership

Company	Insider Ownership
AMN AMN Healthcare Services	0.93%
BRBR BellRing Brands	1.07%
HAE Haemonetics	1.84%
LNTH Lantheus	2.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMN AMN Healthcare Services	2,968	38.28 million	37.93 million	Optionable
BRBR BellRing Brands	380	127.00 million	125.64 million	Optionable
HAE Haemonetics	3,023	48.04 million	47.16 million	Optionable
LNTH Lantheus	700	69.19 million	67.80 million	Optionable

AMN, HAE, BRBR, and LNTH Headlines

Recent News About These Companies

Lantheus Seems Worth The (Very Real) Risks

July 1 at 11:44 AM | seekingalpha.com

Contrasting RBC Life Sciences (OTCMKTS:RBCL) and Lantheus (NASDAQ:LNTH)

July 1 at 3:25 AM | americanbankingnews.com

Peregrine Capital Management LLC Sells 5,148 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 30 at 8:34 AM | marketbeat.com

Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT

June 29 at 10:35 PM | insidermonkey.com

Lisanti Capital Growth LLC Acquires New Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 29 at 6:33 AM | marketbeat.com

Lantheus Holdings Inc Analysis & Opinion (LNTH) - Investing.com

June 28, 2025 | investing.com

LNTH - Lantheus Holdings Inc Trailing Returns | Morningstar

June 26, 2025 | morningstar.comM

Janney Montgomery Scott LLC Increases Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 26, 2025 | marketbeat.com

Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1

June 25, 2025 | msn.com

Lantheus Holdings, Inc. (LNTH) - Yahoo Finance

June 24, 2025 | finance.yahoo.com

Lantheus to Present New Oncology Radiodiagnostic Data at SNMMI Meeting

June 24, 2025 | msn.com

B. Riley Issues Pessimistic Forecast for Lantheus (NASDAQ:LNTH) Stock Price

June 23, 2025 | marketbeat.com

Exchange Traded Concepts LLC Raises Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 21, 2025 | marketbeat.com

Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment

June 21, 2025 | uk.finance.yahoo.com

Riverwater Partners LLC Has $1.40 Million Position in Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 20, 2025 | marketbeat.com

Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives Average Recommendation of "Buy" from Analysts

June 13, 2025 | marketbeat.com

Assenagon Asset Management S.A. Boosts Stock Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH)

June 13, 2025 | marketbeat.com

Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

June 11, 2025 | globenewswire.com

2 Cash-Producing Stocks with Exciting Potential and 1 to Keep Off Your Radar

June 10, 2025 | msn.com

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lantheus Holdings, Inc. (NASDAQ:LNTH)?

June 10, 2025 | finance.yahoo.com

Lantheus to Present at the 2025 Truist Securities MedTech Conference

June 10, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMN, HAE, BRBR, and LNTH Company Descriptions

AMN Healthcare Services NYSE:AMN

$22.00 +1.33 (+6.43%)

Closing price 07/1/2025 03:59 PM Eastern

Extended Trading

$22.00 0.00 (-0.02%)

As of 07/1/2025 07:48 PM Eastern

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

BellRing Brands NYSE:BRBR

$58.74 +0.81 (+1.40%)

Closing price 07/1/2025 03:59 PM Eastern

Extended Trading

$58.76 +0.02 (+0.04%)

As of 07/1/2025 06:31 PM Eastern

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club, food, drug, mass, eCommerce, specialty, and convenience channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Haemonetics NYSE:HAE

$76.39 +1.78 (+2.38%)

Closing price 07/1/2025 03:59 PM Eastern

Extended Trading

$76.63 +0.25 (+0.32%)

As of 04:05 AM Eastern

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Lantheus NASDAQ:LNTH

$79.42 -2.44 (-2.98%)

Closing price 07/1/2025 04:00 PM Eastern

Extended Trading

$80.41 +0.99 (+1.25%)

As of 04:05 AM Eastern

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time